Alivus Life Sciences Q4 Results
- BSE: 543322
- NSE: ALIVUS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
1,065.95
-0.70 (-0.07%)
-0.70 (-0.07%)Volume4.21 K
Updated: Mon 20 Apr, 2026 | 15:28:43
NSE
1,069.40-0.25 (-0.02%)
-0.25 (-0.02%)Volume87.31 K
Updated: Mon 20 Apr, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Alivus Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 467.08 | 486.93 | 0.08% | 409.69 | 14.01% |
| Depreciation/ Amortization | 15.97 | 19.66 | 5.35% | 14.53 | 9.88% |
| Operating Income | 182.46 | 185.96 | 4.18% | 126.91 | 43.77% |
| Net Income | 141.87 | 150.26 | 3.58% | 97.94 | 44.86% |
| Other Operating Expenses Total | 101.80 | 98.83 | 1.21% | 84.20 | 20.90% |
| Net Income Before Taxes | 191.29 | 198.39 | 3.32% | 129.68 | 47.51% |
| Total Revenue | 649.55 | 672.89 | 1.20% | 536.60 | 21.05% |
| Selling/ General/ Admin Expenses Total | 66.72 | 66.37 | 1.57% | 72.26 | -7.66% |
| Diluted Normalized EPS | 11.55 | 13.80 | 3.68% | 7.97 | 44.97% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.